Axsome Therapeutics Inc

-0.31 (-0.40%)
7:59:32 PM EDT: $78.49 +0.64 (+0.82%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)3.38B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$22.38 Million
Adjusted EPS-$1.07
See more estimates
10-Day MA$73.65
50-Day MA$54.82
200-Day MA$43.37
See more pivots

Axsome Therapeutics Inc Stock, NASDAQ:AXSM

22 Cortlandt Street, 16th floor, New York, New York 10007
United States of America
Phone: +1.212.332.3241
Number of Employees: 108


Axsome Therapeutics, Inc. engages in the development of novel therapies for the management of central nervous system disorders. Its product candidates include AXS-05, AXS-07, AXS-12, and AXS-14 which are being developed for multiple pain and primary care indications. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.